Kryogene Cell Freezing Media-CGT

Details

Developed for next-generation cell therapies, Kryogene Cell Freezing Media – CGT delivers a chemically defined, serum- and protein-free cryopreservation solution that supports high cell viability and functional integrity throughout freezing, storage, and post-thaw recovery.

• U.S. FDA Drug Master File (DMF) on file

Product Features

• Optimized for cellular therapies‌: Engineered for CAR-T, NK, MSCs, iPSCs, and other advanced cell therapies.
• Safe & Clinical-grade assurance‌: Designed for clinical-grade cryopreservation with batch-to-batch consistency. Manufactured under current Good Manufacturing Practice (GMP) standards with USP-compliant raw materials to ensure regulatory alignment.
• Superior cryoprotection‌: Minimizes ice crystal formation to preserve cell integrity during freeze-thaw cycles.
• ‌High viability retention‌: Ensures consistent cell function and recovery post-thaw.
• ‌Ready-to-use formulation‌: Eliminates preparation steps—enhances reproducibility and workflow efficiency.
• Batch-to-batch consistency‌: Closed, disposable manufacturing process, ensuring no cross-contamination between batches. Rigorous quality control guarantees uniform performance across all production lots.